Skip to main content
. 2022 May 24;9(1):e001936. doi: 10.1136/openhrt-2021-001936

Figure 3.

Figure 3

The use of dapagliflozin was not associated with a significant deterioration of renal function from randomisation to discharge. eGFR, estimated glomerular filtration rate.